Evaluated articles

Showing page 416 of 1181 pages of list content

SARS‐CoV ‐2 infection impacts carbon metabolism and depends on glutamine for replication in Syrian hamster astrocytes

This article has 38 authors:
1. Lilian Gomes de Oliveira
2. Yan de Souza Angelo
3. Pedro Yamamoto
4. Victor Corasolla Carregari
5. Fernanda Crunfli
6. Guilherme Reis‐de‐Oliveira
7. Lícia Costa
8. Pedro Henrique Vendramini
9. Érica Almeida Duque
10. Nilton Barreto dos Santos
11. Egidi Mayara Firmino
12. Isadora Marques Paiva
13. Glaucia Maria Almeida
14. Adriano Sebollela
15. Carolina Manganeli Polonio
16. Nagela Ghabdan Zanluqui
17. Marília Garcia de Oliveira
18. Patrick da Silva
19. Gustavo Gastão Davanzo
20. Marina Caçador Ayupe
21. Caio Loureiro Salgado
22. Antônio Francisco de Souza Filho
23. Marcelo Valdemir de Araújo
24. Taiana Tainá Silva‐Pereira
25. Angélica Cristine de Almeida Campos
26. Luiz Gustavo Bentim Góes
27. Marielton dos Passos Cunha
28. Elia Garcia Caldini
29. Maria Regina D'Império Lima
30. Denise Morais Fonseca
31. Ana Márcia de Sá Guimarães
32. Paola Camargo Minoprio
33. Carolina Demarchi Munhoz
34. Cláudia Madalena Cabrera Mori
35. Pedro Manoel Moraes‐Vieira
36. Thiago Mattar Cunha
37. Daniel Martins‐de‐Souza
38. Jean Pierre Schatzmann Peron
Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

This article has 4 evaluationsAppears in 2 listsLatest version Aug 15, 2022Latest activity Nov 21, 2021
A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron

This article has 21 authors:
1. Ryota Maeda
2. Junso Fujita
3. Yoshinobu Konishi
4. Yasuhiro Kazuma
5. Hiroyuki Yamazaki
6. Itsuki Anzai
7. Tokiko Watanabe
8. Keishi Yamaguchi
9. Kazuki Kasai
10. Kayoko Nagata
11. Yutaro Yamaoka
12. Kei Miyakawa
13. Akihide Ryo
14. Kotaro Shirakawa
15. Kei Sato
16. Fumiaki Makino
17. Yoshiharu Matsuura
18. Tsuyoshi Inoue
19. Akihiro Imura
20. Keiichi Namba
21. Akifumi Takaori-Kondo
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 6, 2022Latest activity Nov 19, 2021
Mice infected with Mycobacterium tuberculosis are resistant to secondary infection with SARS-CoV-2

This article has 9 authors:
1. Oscar Rosas Mejia
2. Erin S. Gloag
3. Jianying Li
4. Marisa Ruane-Foster
5. Tiffany A. Claeys
6. Daniela Farkas
7. Laszlo Farkas
8. Gang Xin
9. Richard T. Robinson
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 10, 2021Latest activity Nov 19, 2021
SARS-CoV-2 Envelope protein (E) binds and activates TLR2: A novel target for COVID-19 interventions

This article has 5 authors:
1. Rémi Planès
2. Jean-Baptiste Bert
3. Sofiane Tairi
4. Lbachir Benmohamed
5. Elmostafa Bahraoui
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 12, 2021Latest activity Nov 19, 2021
A biosafety level 2 surrogate for studying SARS-CoV-2 survival in food processing environmental biofilms

This article has 2 authors:
1. Austin B. Featherstone
2. Sapna Chitlapilly Dass
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 1, 2021Latest activity Nov 19, 2021
Identification of COVID-19 and COPD common key genes and pathways using a protein-protein interaction approach

This article has 4 authors:
1. Thiviya S. Thambiraja
2. Kalimuthu Karuppanan
3. Gunasekaran Subramaniam
4. Suresh Kumar
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Oct 29, 2021Latest activity Nov 19, 2021
SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade

This article has 9 authors:
1. Firdaus Samsudin
2. Palur Raghuvamsi
3. Ganna Petruk
4. Manoj Puthia
5. Jitka Petrlova
6. Paul MacAry
7. Ganesh S Anand
8. Peter J Bond
9. Artur Schmidtchen
Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

This article has 4 evaluationsAppears in 3 listsLatest version Sep 1, 2022Latest activity Feb 14, 2022
Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease

This article has 10 authors:
1. Bennett J. Davenport
2. Alexis Catala
3. Stuart M. Weston
4. Robert M. Johnson
5. Jeremy Ardanuy
6. Holly L. Hammond
7. Carly Dillen
8. Matthew B. Frieman
9. Carlos E. Catalano
10. Thomas E. Morrison
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 26, 2022Latest activity Nov 19, 2021
Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold

This article has 12 authors:
1. Raphael J. Eberle
2. Ian Gering
3. Markus Tusche
4. Philipp N. Ostermann
5. Lisa Müller
6. Ortwin Adams
7. Heiner Schaal
8. Danilo S. Olivier
9. Marcos S. Amaral
10. Raghuvir K. Arni
11. Dieter Willbold
12. Mônika A. Coronado
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 27, 2022Latest activity Nov 19, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway

This article has 48 authors:
1. Matthew Gagne
2. Kizzmekia S. Corbett
3. Barbara J. Flynn
4. Kathryn E. Foulds
5. Danielle A. Wagner
6. Shayne F. Andrew
7. John-Paul M. Todd
8. Christopher Cole Honeycutt
9. Lauren McCormick
10. Saule T. Nurmukhambetova
11. Meredith E. Davis-Gardner
12. Laurent Pessaint
13. Kevin W. Bock
14. Bianca M. Nagata
15. Mahnaz Minai
16. Anne P. Werner
17. Juan I. Moliva
18. Courtney Tucker
19. Cynthia G. Lorang
20. Bingchun Zhao
21. Elizabeth McCarthy
22. Anthony Cook
23. Alan Dodson
24. Prakriti Mudvari
25. Jesmine Roberts-Torres
26. Farida Laboune
27. Lingshu Wang
28. Adrienne Goode
29. Swagata Kar
30. Seyhan Boyoglu-Barnum
31. Eun Sung Yang
32. Wei Shi
33. Aurélie Ploquin
34. Nicole Doria-Rose
35. Andrea Carfi
36. John R. Mascola
37. Eli A. Boritz
38. Darin K. Edwards
39. Hanne Andersen
40. Mark G. Lewis
41. Mehul S. Suthar
42. Barney S. Graham
43. Mario Roederer
44. Ian N. Moore
45. Martha C. Nason
46. Nancy J. Sullivan
47. Daniel C. Douek
48. Robert A. Seder
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Oct 24, 2021Latest activity Nov 19, 2021
A self-amplifying mRNA COVID-19 vaccine drives potent and broad immune responses at low doses that protects non-human primates against SARS-CoV-2

This article has 15 authors:
1. Amy R. Rappaport
2. Sue-Jean Hong
3. Ciaran D. Scallan
4. Leonid Gitlin
5. Arvin Akoopie
6. Gregory R. Boucher
7. Milana Egorova
8. J. Aaron Espinosa
9. Mario Fidanza
10. Melissa A. Kachura
11. Annie Shen
12. Gloria Sivko
13. Anne Van Abbema
14. Robert L. Veres
15. Karin Jooss
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 9, 2021Latest activity Nov 19, 2021
Multi-label topic classification for COVID-19 literature annotation using an ensemble model based on PubMedBERT

This article has 2 authors:
1. Shubo Tian
2. Jinfeng Zhang
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Oct 29, 2021Latest activity Nov 19, 2021
Phylogenetic analysis and in silico studies link spike Q675H mutation to SARS-CoV-2 adaptive evolution

This article has 9 authors:
1. Bertelli Anna
2. D’Ursi Pasqualina
3. Campisi Giovanni
4. Messali Serena
5. Milanesi Maria
6. Giovanetti Marta
7. Ciccozzi Massimo
8. Caccuri Francesca
9. Caruso Arnaldo
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Oct 29, 2021Latest activity Nov 19, 2021
Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro

This article has 18 authors:
1. Mikhail A. Hameedi
2. Erica T. Prates
3. Michael R. Garvin
4. Irimpan I. Mathews
5. B. Kirtley Amos
6. Omar Demerdash
7. Mark Bechthold
8. Mamta Iyer
9. Simin Rahighi
10. Daniel W. Kneller
11. Andrey Kovalevsky
12. Stephan Irle
13. Van-Quan Vuong
14. Julie C. Mitchell
15. Audrey Labbe
16. Stephanie Galanie
17. Soichi Wakatsuki
18. Daniel Jacobson
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 8, 2022Latest activity Nov 19, 2021
A high-throughput, automated, cell-free expression and screening platform for antibody discovery

This article has 6 authors:
1. Andrew C. Hunt
2. Bastian Vögeli
3. Weston K. Kightlinger
4. Danielle J. Yoesep
5. Antje Krüger
6. Michael C. Jewett
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 5, 2021Latest activity Nov 19, 2021
Whole-Genome Sequencing of Vero E6 (VERO C1008) and Comparative Analysis of Four Vero Cell Sublines

This article has 8 authors:
1. Kazuhiro Konishi
2. Toshiyuki Yamaji
3. Chisato Sakuma
4. Fumio Kasai
5. Toshinori Endo
6. Arihiro Kohara
7. Kentaro Hanada
8. Naoki Osada
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 22, 2022Latest activity Nov 19, 2021
Uptake of COVID-19 Vaccination Among Frontline Workers in California State Prisons

This article has 8 authors:
1. Lea Prince
2. Elizabeth Long
3. David M. Studdert
4. David Leidner
5. Elizabeth T. Chin
6. Jason R. Andrews
7. Joshua A. Salomon
8. Jeremy D. Goldhaber-Fiebert
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 11, 2022Latest activity Nov 22, 2021
Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds

This article has 13 authors:
1. Maxence Meyer
2. Florentin Constancias
3. Claudia Worth
4. Anita Meyer
5. Marion Muller
6. Alexandre Boussuge
7. Georges Kaltenbach
8. Elise Schmitt
9. Saïd Chayer
10. Aurélie Velay
11. Thomas Vogel
12. Samira Fafi-Kremer
13. Patrick Karcher
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 8, 2022Latest activity Nov 22, 2021
Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell

This article has 4 authors:
1. Yanmei Hu
2. Hyunil Jo
3. William F. DeGrado
4. Jun Wang
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 2, 2022Latest activity Nov 19, 2021
Novel pectin from crude polysaccharide of Syzygium aromaticum against SARS-CoV-2 activities by targeting 3CLpro

This article has 14 authors:
1. Can Jin
2. Bo Feng
3. Rongjuan Pei
4. Yaqi Ding
5. Meixia Li
6. Xia Chen
7. Zhenyun Du
8. Yangxiao Ding
9. Chunfan Huang
10. Bo Zhang
11. Xinwen Chen
12. Yi Zang
13. Jia Li
14. Kan Ding
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Oct 29, 2021Latest activity Nov 19, 2021

Evaluated articles

SARS‐CoV ‐2 infection impacts carbon metabolism and depends on glutamine for replication in Syrian hamster astrocytes

A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron

Mice infected with Mycobacterium tuberculosis are resistant to secondary infection with SARS-CoV-2

SARS-CoV-2 Envelope protein (E) binds and activates TLR2: A novel target for COVID-19 interventions

A biosafety level 2 surrogate for studying SARS-CoV-2 survival in food processing environmental biofilms

Identification of COVID-19 and COPD common key genes and pathways using a protein-protein interaction approach

SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade

Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease

Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold

Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway

A self-amplifying mRNA COVID-19 vaccine drives potent and broad immune responses at low doses that protects non-human primates against SARS-CoV-2

Multi-label topic classification for COVID-19 literature annotation using an ensemble model based on PubMedBERT

Phylogenetic analysis and in silico studies link spike Q675H mutation to SARS-CoV-2 adaptive evolution

Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro

A high-throughput, automated, cell-free expression and screening platform for antibody discovery

Whole-Genome Sequencing of Vero E6 (VERO C1008) and Comparative Analysis of Four Vero Cell Sublines

Uptake of COVID-19 Vaccination Among Frontline Workers in California State Prisons

Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds

Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell

Novel pectin from crude polysaccharide of Syzygium aromaticum against SARS-CoV-2 activities by targeting 3CLpro